ArticleHuman vaccines & immunotherapeutics2026
Projected epidemiological impact of lowering the adult pneumococcal vaccination age from 60 to 50 years in Germany.
Oluwaseun Sharomi et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.